Like a Leaf From a Tree: The Gene Patent Ruling

by jeeg 2. August 2011 19:30
Friday's much-anticipated gene-patenting ruling from a federal appeals court reads like a variation on the timeless joke about the legal profession: What do you get when you have three judges writing about the same case? You get four opinions (and a great deal of navel-gazing about the nature ... [More]

Private companies own your DNA – again

by jeeg 1. August 2011 19:09
Many scientists cheered last year when a federal judge ruled that human genes couldn’t be patented. The case involved Myriad Genetics, which holds the patent rights on two genes, BRCA1 and BRCA2, that are associated with increased risks for breast and ovarian cancer. Thanks to these pate... [More]

Federal Judge Hints at Views on Gene Patents

by jeeg 31. August 2010 02:50
In a recent dissent in an unrelated patent case, Federal Circuit Judge Timothy B. Dyk in Intervet v. Merial raises the question as to whether isolated DNA is patentable subject matter.  Dyk's dissent is important as a member of the Federal Circuit to whom the Myriad case has been app... [More]

Myriad Appeals Gene Patent Decision

by jeeg 18. June 2010 00:39
Just over two months ago, in a widely publicized decision we characterized as “a nearly complete victory for the plaintiffs and their supporters,” a district court judge in New York invalidated a number of Myriad Genetics’ patent claims, including the company’s paten... [More]
Log in